Subscribe
Dreamfinity Ltd / Shutterstock.com
24 July 2025NewsEuropeMarisa Woutersen

UPC hands rare default win to Insulet, bans insulin pump in EU

Court delivers default judgment dismissing EOFlow’s patent revocation claim | Dispute escalates following EOFlow’s refusal to post security amid financial concerns | Following detailed analysis, it upholds infringement claims ordering sales ban across 17 countries.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UPC orders 17-country ban on EOFlow's pumps in Insulet feud
2 May 2025   Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation.
Americas
Medical company sees $452m trade secrets award cut by 87%
29 April 2025   US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.
Americas
‘A marathon and a sprint at the same time’: How we won $452m damages
12 December 2024   With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Europe
UPC orders 17-country ban on EOFlow's pumps in Insulet feud
2 May 2025   Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation.
Americas
Medical company sees $452m trade secrets award cut by 87%
29 April 2025   US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.
Americas
‘A marathon and a sprint at the same time’: How we won $452m damages
12 December 2024   With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.

More on this story

Europe
UPC orders 17-country ban on EOFlow's pumps in Insulet feud
2 May 2025   Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation.
Americas
Medical company sees $452m trade secrets award cut by 87%
29 April 2025   US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.
Americas
‘A marathon and a sprint at the same time’: How we won $452m damages
12 December 2024   With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.

More features

GSK loses appeal over purple inhaler TM in Europe
Astellas defends Xtandi patent as court rejects generics’ appeal
Jury sides with Allergan in $56M Botox tech feud
Novartis fails latest bid to block Entresto copies
BMS blocks biosimilar version of blockbuster cancer drug in India
WATCH: Protecting life science innovations involving big data, AI and machine learning
AbbVie blocks Humira antitrust suit
WATCH: Enabling success—mastering s112 in the new era of life sciences patents